Advertisement

Pharmacy Report

10 largest pharma companies by 2020 revenue | Pfizer's COVID antiviral sharply reduces severe illness | Omicron accounts for 3% of new US cases | Duke wins federal contract to make vaccine candidates

December 14, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer says antiviral pill sharply reduces severe illness, should work against omicron Full story 2. 46 top hospitals, ranked by Leapfrog Full story 3. 10 of the largest pharma companies, ranked…

Pfizer to buy Arena for $6.7B | CVS in 2021: Timeline of key events | Pharmacy owner convicted in $174M telehealth scheme | Vaccines' protection against omicron: What we know | 9 hospital CEOs sound alarm over Minn. COVID surge

December 13, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer to acquire Arena Pharmaceuticals for $6.7B Full story 2. Florida pharmacy owner found guilty of running $174M telehealth fraud scheme Full story 3. What we know about vaccines' protection against…

FDA clears Pfizer booster for teens 16-17 | CDC vaccine data may be inaccurate | Allergan settles NY opioid case for $200M | Antibody drug authorized for COVID prevention | 11 systems pausing elective surgeries | 4 Qs on boosters, answered

December 9, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. FDA authorizes Pfizer booster for 16- and 17-year-olds Full story 2. Brigham and Women's touts accuracy of digital pill system Full story 3. Some CDC vaccination figures may be…

Pfizer booster strongly protects against omicron | Martin Shkreli's former drug company to pay $40M over price-gouging | 6 states tied to 60% of US COVID hospitalizations | Vaccinations up in 46 states

December 8, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer says its booster provides strong protection against omicron Full story 2. Vyera Pharmaceuticals to pay $40M in price-gouging settlement Full story 3. Boston pharmacies struggle to meet demand for at-home…

GSK antibody drug effective against omicron | Centene pays $27.6M to settle drug overbilling claims | 5 states set COVID records | Biden touts drug cost measures in spending bill | Safety alert issued over COVID vaccine mix-ups

December 7, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. GlaxoSmithKline says its antibody drug is effective against omicron Full story 2. 5 states set COVID-19 records this week Full story 3. Centene to pay Kansas $27.6M to settle drug overbilling…

Advertisement

US to expedite COVID shots redesigned for omicron | Eli Lilly antibody drug authorized for kids | Omicron may be less severe than delta | UPMC finds merit in giving antibodies via injection | Report: 12.8M adults delay, skip prescriptions each year

December 6, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. US to accelerate authorization of COVID-19 vaccines redesigned for omicron Full story 2. Omicron may be less severe than delta, early reports suggest Full story 3. FDA authorizes Eli Lilly's COVID-19…

CVS, Microsoft partner on digital care | Pharmacists to CMS: Require COVID pill dispensing fee | Omicron found in Minn. | PBMs' profits are up, revenue sources unclear: report | 5 systems suspend vaccination mandates

December 2, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. CVS, Microsoft forge digital care partnership Full story 2. 5 health systems suspending vaccination mandates Full story 3. Pharmacists urge CMS to require fee for dispensing COVID-19 antivirals Full story 4. Aligning people,…

FDA panel backs Merck's COVID pill | Regeneron antibody drug may be less effective against omicron | Healthcare worker vaccination rule blocked nationwide | 5 drugs to watch in late 2021 | Vaccinations down in 45 states

December 1, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. FDA advisers recommend Merck's COVID-19 pill for authorization Full story 2. Antibody drug may be less effective against omicron, Regeneron says Full story 3. Pfizer asks FDA to authorize boosters for…

Amazon, Gilead partner on AI-powered drug discovery | CDC strengthens booster recommendation | Pfizer expects COVID antiviral to work against omicron | Healthcare worker vaccine rule blocked in 10 states | GSK names vaccine chief

November 30, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer expects COVID-19 antiviral to work against omicron Full story 2. Amazon inks cloud partnership with Gilead to facilitate AI-powered drug discovery Full story 3. GSK appoints new vaccine…

Pfizer, Moderna ready to reformulate COVID shots: 10 omicron updates | Merck's antiviral less effective in final study | Mich. COVID surge intensifies | 'Vaccine' crowned Merriam-Webster's word of the year

November 29, 2021 BHR Newsletter Virtual Events  •  Webinars   •   Whitepapers   •   OnDemand Learning  •   Podcasts 1. Pfizer, Moderna ready to reformulate COVID vaccines, if needed: 10 omicron updates Full story 2. CEO of Washington hospital resigns after 2 years Full story 3. Merck's full study results show…

Advertisement